Nanobiotix appoints CordenPharma as CMO for potential nanoparticle-based cancer treatment

By Zachary Brennan contact

- Last updated on GMT

Nanobiotix appoints CordenPharma as CMO for potential nanoparticle-based cancer treatment

Related tags: Cancer

The late clinical-stage nanomedicine company Nanobiotix has selected CordenPharma as its contract manufacturing partner. 

The deal comes as CordenPharma plans to open a new manufacturing line at its France site, which is one of eight cGMP facilities across Europe and the US, and the new line will increase production capacity 25-fold. 

The new line is expected manufacture NBTXR3, Nanobiotix’s lead product, which is comprised of Hafnium Oxide nanoparticles that can be injected directly into tumors. With the application of radiotherapy, these nanoparticles absorb X-rays and have the potential to significantly enhance the radiation dose within the cancer cells without increasing the dose to the surrounding healthy tissues, the company says. 

Nanobiotix expects its product to win CE marking in 2016, and is therefore preparing to scale-up production to meet the needs of the expected commercialization. The company also anticipates future demand from clinical trials in the coming years in Europe and the US.  

Yves Michon, president of CordenPharma said: “Nanobiotix’s product, NBTXR3 is a fascinating product – not only with respect to its properties, but also in its manufacture. We are working closely with Nanobiotix to ensure a seamless process and manage the scale-up of the product.​”

Related news

Show more

Related products

show more

Flexible Filling Solution for CMOs

Flexible Filling Solution for CMOs

Single Use Support GmBH | 18-May-2022 | Insight Guide

Achieving flexibility requires modularity of technologies.

CMOs and CDMOs aspire to be flexible for multiple applications. Efficient automated...

Governing and Maintaining Clinical Data Standards

Governing and Maintaining Clinical Data Standards

Veeva | 10-May-2022 | Technical / White Paper

Investing in data standards plays a huge role in improving the quality of clinical studies. But often, people don’t use the standards correctly, there...

What the Best Clinical Study Build Pros Do

What the Best Clinical Study Build Pros Do

Formedix | 09-May-2022 | Technical / White Paper

Getting your clinical study designed and built ready for data collection takes A LOT of work and expertise… you've got to do all your CRF designs;...

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 18-Apr-2022 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Related suppliers

Follow us

Products

View more

Webinars